MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

BACKGROUND: Advanced non‐small cell lung cancer (NSCLC) has a high mortality rate and poor prognosis. However, outcomes have gradually improved after the introduction of novel immunotherapies, including immune checkpoint inhibitors (ICIs). Although programmed death‐ligand 1 (PD‐L1) expression in tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Katakura, Seigo, Kobayashi, Nobuaki, Hashimoto, Hisashi, Kamimaki, Chisato, Tanaka, Katsushi, Kubo, Sousuke, Nakashima, Kentaro, Teranishi, Shuhei, Manabe, Saki, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Yamamoto, Masaki, Kudo, Makoto, Piao, Hongmei, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529545/
https://www.ncbi.nlm.nih.gov/pubmed/32893980
http://dx.doi.org/10.1111/1759-7714.13653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529545/
https://www.ncbi.nlm.nih.gov/pubmed/32893980
http://dx.doi.org/10.1111/1759-7714.13653

Ejemplares similares